US 12,419,944 B2
DNABII vaccines and antibodies with enhanced activity
Lauren O. Bakaletz, Hilliard, OH (US); and Steven D. Goodman, Hilliard, OH (US)
Assigned to Research Institute at Nationwide Children's Hospital, Columbus, OH (US)
Filed by Research Institute at Nationwide Children's Hospital, Columbus, OH (US)
Filed on Oct. 18, 2022, as Appl. No. 18/047,619.
Application 18/047,619 is a division of application No. 16/475,656, granted, now 11,564,982, previously published as PCT/US2018/012235, filed on Jan. 3, 2018.
Claims priority of provisional application 62/455,437, filed on Feb. 6, 2017.
Claims priority of provisional application 62/453,921, filed on Feb. 2, 2017.
Claims priority of provisional application 62/442,307, filed on Jan. 4, 2017.
Prior Publication US 2023/0190908 A1, Jun. 22, 2023
Int. Cl. A61K 39/102 (2006.01); A01N 63/50 (2020.01); A61K 45/06 (2006.01); A61P 31/04 (2006.01); C07K 14/285 (2006.01); C07K 16/12 (2006.01); G01N 33/569 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01)
CPC A61K 39/102 (2013.01) [A01N 63/50 (2020.01); A61K 45/06 (2013.01); A61P 31/04 (2018.01); C07K 14/285 (2013.01); C07K 16/1242 (2013.01); G01N 33/56911 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/20 (2013.01); C07K 2317/24 (2013.01); C07K 2317/55 (2013.01); C07K 2319/00 (2013.01); G01N 2333/285 (2013.01)] 54 Claims
 
1. A polynucleotide encoding a polypeptide comprising the polypeptide of SEQ ID NO: 50.